A pooled analysis investigated the prognostic role of DNA mismatch repair status in patients with stage III colon cancer treated with a standard adjuvant chemotherapy regimen. READ MORE

Conferences

Important factors to consider when developing a clinical pathway for colorectal cancer.

READ MORE

Chemoradiotherapy and post-operative chemotherapy may be equally effective when treating patients with gastric cancer.

READ MORE

Lymph node ratio may be a significant indicator of prognosis in patients with rectal cancer and could be used to better stratify patients in trials.

READ MORE

The physical location of a primary tumor may be an indicator of survivor in patients with metastatic colorectal cancer. 

READ MORE

News

Systemic inflammation combined with sarcopenia could double the risk of death in patients with colorectal cancer, suggesting that these markers have clinical predictive value.

READ MORE

For patients with complications after colorectal surgery, being readmitted to the same medical center and being cared for by the surgeon who performed the operation may increase the likelihood of survival.

READ MORE

Research in Review

Patients aged 45 years or younger with colorectal cancer may have better treatment options available to them because of more mutations in their tumors than older patients.

READ MORE

Patients with rectal cancer who undergo first-line chemotherapy and radiation have lower risk of recurrence and higher rates of survival regardless of whether they choose to have surgery.

READ MORE

Patients with colorectal cancer can decrease their risk of disease-related mortality by 54% if they consume certain types of food.

READ MORE

Patients with a specific type of metastatic colorectal cancer who are chemotherapy-resistant benefit from treatment with a gene-targeting regimen.

READ MORE